Paradigm Biopharmaceuticals Ltd.'s total assets for Q4 2024 were AU$27.39M, a decrease of -39.18% from the previous quarter. PBIGF total liabilities were AU$3.58M for the fiscal quarter, a -68.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.